| Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation C Bárcena, M Stefanovic, A Tutusaus, L Joannas, A Menéndez, ... Journal of hepatology 63 (3), 670-678, 2015 | 126 | 2015 |
| Growth arrest–specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury L Llacuna, C Bárcena, L Bellido‐Martín, L Fernández, M Stefanovic, ... Hepatology 52 (4), 1371-1379, 2010 | 87 | 2010 |
| Angiogenin secretion from hepatoma cells activates hepatic stellate cells to amplify a self-sustained cycle promoting liver cancer C Bárcena, M Stefanovic, A Tutusaus, GA Martinez-Nieto, L Martinez, ... Scientific reports 5 (1), 7916, 2015 | 60 | 2015 |
| CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78) G Aran, L Sanjurjo, C Barcena, M Simon‐Coma, É Téllez, ... The FASEB Journal 32 (7), 3878-3891, 2018 | 54 | 2018 |
| Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma M Stefanovic, A Tutusaus, GA Martinez-Nieto, C Bárcena, E de Gregorio, ... Oncotarget 7 (7), 8253, 2016 | 52 | 2016 |
| CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content C Bárcena, G Aran, L Perea, L Sanjurjo, É Téllez, A Oncins, H Masnou, ... EBioMedicine 43, 513-524, 2019 | 35 | 2019 |
| GD3 synthase overexpression sensitizes hepatocarcinoma cells to hypoxia and reduces tumor growth by suppressing the cSrc/NF-κB survival pathway JM Lluis, L Llacuna, C von Montfort, C Barcena, C Enrich, A Morales, ... PloS one 4 (11), e8059, 2009 | 30 | 2009 |
| Fibre-type-specific and mitochondrial biomarkers of muscle damage after mountain races G Carmona, E Roca, M Guerrero, R Cussó, C Bàrcena, M Mateu, ... International journal of sports medicine 40 (04), 253-262, 2019 | 17 | 2019 |
| Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma. Oncotarget. 2016; 7: 8253–8267 M Stefanovic, A Tutusaus, GA Martinez-Nieto, C Bárcena, E de Gregorio, ... | 5 | |
| 100 propuestas para mejorar la competencia matemática C Bárcena, F Cortiguera, M Fuentes, D Gabarró, J López, J Medina, ... España, Santillana, 2009 | 4 | 2009 |
| Targeting AXL signaling-A new strategy to reduce HSC activation and liver fibrosis C Bárcena, M Stefanovic, GA Martínez-Nieto, JC Fernández-Checa, ... | 1 | 2013 |
| Fibre-type-specific and Mitochondrial Biomarkers of Muscle Damage after Mountain Races G Carmona Dalmases, E Roca, M Guerrero, MR Cussó Fresquet, ... International Journal of Sports Medicine, 2019, vol. 40, num. 4, p. 253-262, 2019 | | 2019 |
| CD5L modulates primary human hepatic stellate cells activation C Barcena, G Aran, L Perea, L Sanjurjo, C Armengol, P Sancho-Bru, ... Journal of Hepatology 1 (66), S649, 2017 | | 2017 |
| The Macrophage Protein CD5L Acts as a Pro-Oncogenic Factor in Hepatocytes G Aran, L Sanjurjo, C Bárcena, M Javid, M Simon, M Vázquez, E Díaz, ... Journal of Hepatology 2 (64), S565, 2016 | | 2016 |
| Targeting glucosylceramide synthase increases sorafenib efficacy and evades sorafenib resistance in HCC models M Stefanovic, A Tutusaus, C Bárcena, GA Martínez-Nieto, M Marí, ... | | 2015 |
| Participación de la proteina gas6 en el daño hepático por fibrosis e isquemia/reperfusión C Bárcena CSIC-Instituto de Investigaciones Biomédicas de Barcelona (IIBB), 2014 | | 2014 |
| P611 GAS6/AXL AXIS AS PROGNOSTIC AND THERAPEUTIC TARGET IN LIVER DISEASE C Barcena, M Stefanovic, A Tutusaus, L Joannas, J Caballeria, M Mari, ... Journal of Hepatology 1 (60), S273, 2014 | | 2014 |
| HCC-Secreted angiogenin promotes HSC activation providing profibrogenic environment for tumor growth C Bárcena, M Stefanovic, GA Martínez-Nieto, JC Fernández-Checa, ... Elsevier, 2013 | | 2013 |
| 310 SORAFENIB INDUCTION OF SPHINGOLIPIDIC METABOLISM REVEALS CERAMIDASE TARGETING AS A POTENTIAL STRATEGY IN HCC TREATMENT M Stefanovic, C Bárcena, C García-Ruiz, JC Fernández-Checa, ... Journal of Hepatology, S127, 2012 | | 2012 |
| Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury L Llacuna Duran, C Bárcena, L Bellido-Martín, L Fernández Fernández, ... Wiley-Blackwell, 2010 | | 2010 |
Montserrat MaríInvestigadora Científica IIBB-CSIC/IDIBAPSVerified email at iibb.csic.es
